Clinical Trial Update: Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating higher-dose ezetimibe for treating homozygous sitosterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sitosterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Heart Diseases, Metabolism, Inborn Errors | Phase 3 | Status: COMPLETED